$2.40
▲ +6.2% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
Veru And 2 Other Intriguing Penny Stocks To Watch
Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru Trial
Overview
52-week range
$2.05
$7.40
7% of range
Avg surprise (last 3)
+30.2%
Avg reaction (last 2)
+1.8%
50% positive
Latest IV / EM
599%
EM ±35.4% · $3 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.13 | $-0.37 | +64.9% | -160.0% | -0.4% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.50 | $-0.55 | +9.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.05 | $-0.06 | +16.7% | — | +4.0% | earnings |
| Sun Mar 31, 2024 | Mar 2024 | $-0.07 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.34 | -$0.50 | +32.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | $3M |
| Gross profit | — | — | — | — | — | — | — | $1M |
| Operating income | $-7M | $-5M | — | $-8M | $-8M | $-10M | — | $-11M |
| Net income | $-3M | $-5M | — | $-7M | $-8M | $-9M | — | $-11M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $28M | $33M | $16M | $15M | $20M | $27M | $25M | $29M |
| Inventory | — | — | — | — | — | — | — | $5M |
| Total current assets | $33M | $37M | $19M | $16M | $21M | $28M | $35M | $38M |
| Total assets | $43M | $48M | $30M | $27M | $33M | $40M | $60M | $65M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $10M | $12M | $12M | $12M | $13M | $28M | $27M |
| Total equity | $35M | $37M | $18M | $15M | $21M | $27M | $32M | $38M |